Ask VialBase
weight · loss

Pramlintide

FDA: FDA-approved

Pramlintide is an analog of the hormone amylin, co-secreted with insulin by pancreatic beta cells. It slows gastric emptying, suppresses post-meal glucagon, and promotes satiety, improving blood glucose control in type 1 and type 2 diabetes. Analog of amylin, a hormone co-secreted with insulin by pancreatic beta cells. Slows gastric emptying to reduce post-meal glucose spikes. Suppresses post-meal glucagon secretion. Promotes satiety and reduces food intake. Complements insulin action through a different mechanism. - Blood sugar control improvement - Satiety support and appetite reduction - Post-meal glucose spike reduction - Type 1 and type 2 diabetes management - Weight management

This content is for educational and research purposes only. VialBase does not provide medical advice. Consult a healthcare professional before using any peptide.

Molecular weight —
Half-life —
CAS number 151126-32-8
Route —
What bloodwork do I need?

Reference ranges are general guidelines. Consult your physician for interpretation.

PRE-CYCLE
  • CMP
  • CBC
  • Fasting Glucose
  • HbA1c
  • Fasting Insulin
DURING CYCLE
  • Fasting Glucose
  • HbA1c
POST-CYCLE
  • CMP
  • Fasting Glucose
  • HbA1c
Safety & Regulatory Status
FDA STATUS FDA-approved

Regulatory status for Pramlintide may change. Verify current status with your jurisdiction before use. This is not legal or medical advice.

Frequently Asked Questions

What is Pramlintide?
Pramlintide is an analog of the hormone amylin, co-secreted with insulin by pancreatic beta cells. It slows gastric emptying, suppresses post-meal glucagon, and promotes satiety, improving blood glucose control in type 1 and type 2 diabetes.
How does Pramlintide work?
Analog of amylin, a hormone co-secreted with insulin by pancreatic beta cells. Slows gastric emptying to reduce post-meal glucose spikes. Suppresses post-meal glucagon secretion.
How is Pramlintide dosed?
Standard: 15-120 mcg SubQ before meals, titrated individually; Route: SubQ injection; Note: Nausea is common during initiation -- start low and titrate up. These figures reflect commonly cited research protocols, not medical advice — consult a clinician.
Is Pramlintide FDA-approved?
Pramlintide is FDA-approved. FDA-approved for adjunct use with insulin in type 1 and type 2 diabetes; Available via prescription (marketed as Symlin); Medical supervision required.